CD19 and neoplasm: The combination therapy of OV19t/oncolytic viruses encoding the murine CD19t (OVm19t) protein and CD19-CAR T-cells showed durable and effective anti-tumor effects in MDA-MB-468/U251T bearing human tumor xenograft models and a MC38 bearing immunocompetent murine syngeneic tumor models.